摘要
胃癌是全球最常见的恶性肿瘤之一。目前,针对晚期胃癌的多种治疗方法难以达到令人满意的生存率,因此开发新的治疗方法显得尤为迫切。近10年来,免疫治疗的快速发展为胃癌患者带来了新的希望,特别是肿瘤疫苗疗法成为该领域的一颗新星。疫苗疗法能够激发特异性淋巴细胞,引发对肿瘤抗原的强烈免疫应答。本文介绍了不同类型的肿瘤抗原并总结了目前各种治疗性胃癌疫苗的现状,包括蛋白质/肽疫苗、基因疫苗、细胞疫苗和载体疫苗,特别强调了相关基础或临床试验的研究结果,最后探讨了个性化胃癌疫苗所面临的挑战以及未来的潜在发展方向。
Gastric cancer ranks among the most prevalent malignant tumors globally.Presently,diverse treatment approaches for advanced gastric cancer fall short of achieving satisfactory survival rates,therefore,developing new treatment methods is particularly urgent.Over the last decade,the rapid progress in immunotherapy has brought fresh hope for gastric cancer patients,notably with tumor vaccine therapy emerging as a promising player in this domain.Vaccine therapy can stimulate an increase in specific lymphocytes,eliciting a robust immune response against tumor antigens.This review introduces different types of tumor antigens and summarizes the current status of therapeutic gastric cancer vaccines,including protein/peptide vaccines,gene vaccines,cell vaccines,and vector vaccines.The research outcomes of relevant basic or clinical trials are particularly emphasized.Lastly,the challenges and potential development directions for personalized gastric cancer vaccines are discussed.
作者
刘硕
朱丽慧
蔡辉
LIU Shuo;ZHU Lihui;CAI Hui(The First School of Clinical Medicine,Lanzhou University,Lanzhou 730000,Gansu Province,China;School of Clinical Medicine,Ningxia Medical University,Yinchuan 750000,Ningxia Hui Autonomous Region,China;NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor,Gansu Provincial Hospital,Lanzhou 730000,Gansu Province,China;Gansu Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology,Gansu Provincial Hospital,Lanzhou 730000,Gansu Province,China)
出处
《解放军医学院学报》
CAS
2024年第2期199-204,209,共7页
Academic Journal of Chinese PLA Medical School
基金
2021年中央引导地方科技发展计划(ZYYDDFFZZJ-1)
国家卫健委胃肠肿瘤诊疗重点实验室(2019PT320005)
甘肃省外科肿瘤分子诊断与精准治疗重点实验室(18JR2RA033)。
关键词
胃癌
肿瘤疫苗
特异性免疫
肿瘤抗原
免疫治疗
gastric cancer
cancer vaccines
adaptive immunity
neoplasm antigens
immunotherapy
